The electrical conductivity of in vivo human uterine fibroids

被引:13
作者
Delonzor, Russ [1 ]
Spero, Richard K. [1 ]
Williams, Joseph J. [2 ]
机构
[1] Halt Med Inc, Brentwood, CA USA
[2] Williams Consulting, Sacramento, CA USA
关键词
Thermal ablation; electrical conductivity; thermal modelling; uterine fibroids; RADIOFREQUENCY THERMAL ABLATION; RANDOMIZED CONTROLLED-TRIAL; RADIO-FREQUENCY ABLATION; DIELECTRIC-PROPERTIES; BIOLOGICAL TISSUES; FOLLOW-UP; MYOMAS; SURGERY; VERTEBROPLASTY; EMBOLIZATION;
D O I
10.3109/02656736.2011.555875
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to determine the value of electrical conductivity that can be used for numerical modelling in vivo radiofrequency ablation (RFA) treatments of human uterine fibroids. No experimental electrical conductivity data have previously been reported for human uterine fibroids. In this study electrical data (voltage) from selected in vivo clinical procedures on human uterine fibroids were used to numerically model the treatments. Measured versus calculated power dissipation profiles were compared to determine uterine fibroid electrical conductivity. Numerical simulations were conducted utilising a wide range of values for tissue thermal conductivity, heat capacity and blood perfusion coefficient. The simulations demonstrated that power dissipation was insensitive to the exact values of these parameters for the simulated geometry, treatment duration, and power level. Consequently, it was possible to determine tissue electrical conductivity without precise knowledge of the values for these parameters. Results of this study showed that an electrical conductivity for uterine fibroids of 0.305 S/m at 37 degrees C and a temperature coefficient of 0.2%/degrees C can be used for modelling Radio Frequency Ablation of human uterine fibroids at a frequency of 460 kHz for temperatures from 37 degrees C to 100 degrees C.
引用
收藏
页码:255 / 265
页数:11
相关论文
共 33 条
[1]  
[Anonymous], 2010, OBSTET GYNECOL
[2]   Laparoscopic radiofrequency thermal ablation: A new approach to symptomatic uterine myomas [J].
Bergamini, V ;
Ghezzi, F ;
Cromi, A ;
Bellini, G ;
Zanconato, G ;
Scarperi, S ;
Franchi, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (03) :768-773
[3]   A randomised controlled trial comparing GnRH antagonist Cetrorelix with GnRH agonist Leuprorelin for endometrial thinning prior to transcervical resection of [J].
Bhatia, K. ;
Doonan, Y. ;
Giannakou, A. ;
Bentick, B. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (10) :1214-1224
[4]   TIME-TEMPERATURE ANALYSIS OF CELL KILLING OF BHK CELLS HEATED AT TEMPERATURES IN THE RANGE OF 43.5-DEGREES-C TO 57.0-DEGREES-C [J].
BORRELLI, MJ ;
THOMPSON, LL ;
CAIN, CA ;
DEWEY, WC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (02) :389-399
[5]   Uterine fibroid embolization: a viable alternative to hysterectomy [J].
Bradley, Linda D. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (02) :127-135
[6]   Thermal modeling of lesion growth with radiofrequency ablation devices [J].
Chang, Isaac A. ;
Nguyen, Uyen D. .
BIOMEDICAL ENGINEERING ONLINE, 2004, 3 (1)
[7]   Transvaginal radiofrequency thermal ablation: A day-care approach to symptomatic uterine myomas [J].
Cho, Hyun Hee ;
Kim, Jin Hong ;
Kim, Mee Ran .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2008, 48 (03) :296-301
[8]   Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation - A randomized controlled trial [J].
Doukas, G ;
Samani, NJ ;
Alexiou, C ;
Oc, M ;
Chin, DT ;
Stafford, PG ;
Ng, LL ;
Spyt, TJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (18) :2323-2329
[9]  
DUCK F, 1990, PHYS PROPERTIES TISS, P14
[10]   Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up [J].
Funaki, K. ;
Fukunishi, H. ;
Sawada, K. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2009, 34 (05) :584-589